vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Root, Inc. (ROOT). Click either name above to swap in a different company.
Root, Inc. is the larger business by last-quarter revenue ($397.0M vs $270.8M, roughly 1.5× HUTCHMED (China) Ltd). On growth, Root, Inc. posted the faster year-over-year revenue change (21.5% vs -16.5%).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Root Insurance Company is an online car insurance company operating in the United States.
HCM vs ROOT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $397.0M |
| Net Profit | $2.0M | — |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | 2.6% |
| Net Margin | 0.7% | — |
| Revenue YoY | -16.5% | 21.5% |
| Net Profit YoY | -83.6% | — |
| EPS (diluted) | $0.00 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $397.0M | ||
| Q3 25 | — | $387.8M | ||
| Q2 25 | $277.7M | $382.9M | ||
| Q1 25 | $324.5M | $349.4M | ||
| Q4 24 | — | $326.7M | ||
| Q3 24 | — | $305.7M | ||
| Q2 24 | $305.7M | $289.2M | ||
| Q1 24 | — | $254.9M |
| Q4 25 | $2.0M | — | ||
| Q3 25 | — | $-5.4M | ||
| Q2 25 | $455.0M | $22.0M | ||
| Q1 25 | $11.9M | $18.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $22.8M | ||
| Q2 24 | $25.8M | $-7.8M | ||
| Q1 24 | — | $-6.2M |
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | -13.2% | 2.6% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | -1.3% | 7.1% | ||
| Q1 25 | -5.0% | 6.8% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | -9.0% | 1.3% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | 0.7% | — | ||
| Q3 25 | — | -1.4% | ||
| Q2 25 | 163.8% | 5.7% | ||
| Q1 25 | 3.7% | 5.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 7.5% | ||
| Q2 24 | 8.4% | -2.7% | ||
| Q1 24 | — | -2.4% |
| Q4 25 | $0.00 | $0.35 | ||
| Q3 25 | — | $-0.35 | ||
| Q2 25 | $0.52 | $1.29 | ||
| Q1 25 | $0.01 | $1.07 | ||
| Q4 24 | — | $1.42 | ||
| Q3 24 | — | $1.35 | ||
| Q2 24 | $0.03 | $-0.52 | ||
| Q1 24 | — | $-0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $669.3M |
| Total DebtLower is stronger | $93.2M | $200.3M |
| Stockholders' EquityBook value | $1.2B | $284.3M |
| Total Assets | $1.8B | $1.7B |
| Debt / EquityLower = less leverage | 0.08× | 0.70× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $669.3M | ||
| Q3 25 | — | $653.3M | ||
| Q2 25 | $1.4B | $641.4M | ||
| Q1 25 | $836.1M | $609.4M | ||
| Q4 24 | — | $599.3M | ||
| Q3 24 | — | $674.8M | ||
| Q2 24 | $802.5M | $667.2M | ||
| Q1 24 | — | $640.5M |
| Q4 25 | $93.2M | $200.3M | ||
| Q3 25 | — | $200.4M | ||
| Q2 25 | $93.4M | $200.1M | ||
| Q1 25 | $82.8M | $200.0M | ||
| Q4 24 | — | $200.1M | ||
| Q3 24 | — | $300.9M | ||
| Q2 24 | $82.1M | $300.1M | ||
| Q1 24 | — | $299.3M |
| Q4 25 | $1.2B | $284.3M | ||
| Q3 25 | — | $265.0M | ||
| Q2 25 | $1.2B | $244.5M | ||
| Q1 25 | $759.9M | $228.7M | ||
| Q4 24 | — | $203.7M | ||
| Q3 24 | — | $181.9M | ||
| Q2 24 | $740.1M | $151.3M | ||
| Q1 24 | — | $165.7M |
| Q4 25 | $1.8B | $1.7B | ||
| Q3 25 | — | $1.6B | ||
| Q2 25 | $1.8B | $1.6B | ||
| Q1 25 | $1.3B | $1.6B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | $1.3B | $1.5B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | 0.08× | 0.70× | ||
| Q3 25 | — | 0.76× | ||
| Q2 25 | 0.08× | 0.82× | ||
| Q1 25 | 0.11× | 0.87× | ||
| Q4 24 | — | 0.98× | ||
| Q3 24 | — | 1.65× | ||
| Q2 24 | 0.11× | 1.98× | ||
| Q1 24 | — | 1.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $206.5M |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 1.8% | 0.0% |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $206.5M | ||
| Q3 25 | — | $57.6M | ||
| Q2 25 | $-72.9M | $52.0M | ||
| Q1 25 | $40.3M | $26.8M | ||
| Q4 24 | — | $195.7M | ||
| Q3 24 | — | $49.4M | ||
| Q2 24 | $-39.8M | $62.6M | ||
| Q1 24 | — | $14.5M |
| Q4 25 | $3.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-82.2M | — | ||
| Q1 25 | $32.5M | — | ||
| Q4 24 | — | $195.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | $-49.9M | $62.4M | ||
| Q1 24 | — | $14.3M |
| Q4 25 | 1.2% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -29.6% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | — | 59.8% | ||
| Q3 24 | — | — | ||
| Q2 24 | -16.3% | 21.6% | ||
| Q1 24 | — | 5.6% |
| Q4 25 | 1.8% | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 3.3% | 0.0% | ||
| Q1 25 | 2.4% | 0.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 3.3% | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.16× | 2.36× | ||
| Q1 25 | 3.38× | 1.46× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.17× | ||
| Q2 24 | -1.54× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
